过去一年中添加的文章,按日期排序

Camrelizumab Combined with Apatinib for Portal Vein Tumor Thrombus in Advanced Hepatocellular Carcinoma: Two Case Reports

N Chen, L Zhang, A Gao, L Piao… - British Journal of …, 2024 - magonlinelibrary.com
1 天前 - … (PVTT) is a common complication of primary hepatocellular carcinoma (HCC).
HCC … Combination therapy, including immunotherapy and targeted therapy, shows promise …

Target engagement of the subgenual anterior cingulate cortex with transcranial temporal interference stimulation in major depressive disorder: a protocol for a …

I Demchenko, S Rampersad, A Datta, A Horn… - Frontiers in … - frontiersin.org
2 天前 - … The primary objective is to demonstrate target engagement of the sgACC with
130 Hz … imaging (MRI) techniques. The secondary objective is to estimate the therapeutic

[HTML][HTML] Cardiac Dysfunction in Children and Young Adults Treated With MEK Inhibitors: A Retrospective, Single-Center Study

JD Bender, N Pillay-Smiley, GD Hill, P de Blank… - Cardio Oncology, 2024 - jacc.org
2 天前 - … The primary outcome was the development of moderate International Cardio-Oncology
Society (IC-OS) cancer therapy–related cardiac dysfunction (CTRCD), defined as an on-…

[PDF][PDF] INVERSION OF BRONCHIAL ANATOMY AND LUNG SEGMENTS IN KARTAGENER SYNDROME: A RETROSPECTIVE ANALYSIS OF FIVE SITUS INVERSUS …

T Chand, RK Gupta, SP Azhagappan, FNA Mubaruck - researchgate.net
3 天前 - … these unique presentations can inform targeted therapies and surgical planning,
ultimately … High prevalence of primary ciliary dyskinesia in a British Asian population. Arch Dis …

[PDF][PDF] Cone-Beam Computed Tomography (CBCT)-Guided Adaptive Boost Radiotherapy for a Patient With Locally Advanced Cervical Cancer Ineligible for …

AE Silberstein, JP Schiff, R Beckert, X Zhao… - Cureus, 2024 - cureus.com
3 天前 - … with concurrent weekly carboplatin, followed by a boost to her primary tumor. EBRT
consisted of 50.4 Gy in 28 fractions to her primary mass, pelvic nodes, and para-aortic nodes…

NVTG-05 LONGITUDINAL OBSERVATION OF THE TREATMENT RESPONSE TO INTRATHECAL CHEMOTHERAPY WITH PEMETREXED VIA CIRCULATING …

W Hong, Y Yang, H Wang, Q Liu, J Zhen… - Neuro-Oncology …, 2024 - ncbi.nlm.nih.gov
3 天前 - … Although targeting therapies, particularly tyrosine-kinase inhibitors (TKI), are
effective against primary tumors, the blood-brain barrier may limit their intracranial performance, …

29 Pilot study of an implantable microdevice forin vivo evaluation of drug response in renal cell carcinoma (NCT05700461)

W Xu, S Bhagavatula, C Steiner, C Zhong… - The …, 2024 - academic.oup.com
4 天前 - Background There are multiple therapies for renal cell carcinoma (RCC), yet no
personalized biomarkers exist that can guide optimal treatment for individual patients. We …

Artificial intelligence-enabled advanced endoscopic imaging to assess deep healing in inflammatory bowel disease

Y Maeda, I Ditonno, M Puga-Tejada… - …, 2024 - egastroenterology.bmj.com
5 天前 - Therapeutic Targets in Inflammatory Bowel Disease II international guidelines, the
primary long-term therapeutic … However, there is an ongoing evolution in therapeutic targets, …

Engineering a NanoBiT biosensor for detecting angiotensin-converting enzyme-2 (hACE2) interaction with SARS-CoV-2 spike protein and screening the inhibitors to …

CH Lin, XR Yang, MW Lin, HJ Chang, CH Lee… - Biosensors and …, 2024 - Elsevier
6 天前 - … This critical interaction facilitates viral entry and is a primary target for therapeutic
intervention against COVID-19. However, it is difficult to fully optimize viral infection using …

[HTML][HTML] PD-1 inhibitor in the treatment of relapsed primary mediastinal large B-cell lymphoma follow up by 18F-FDG PET/CT: A case report and literature review

CI Tou, LF Ma - Radiology Case Reports, 2024 - Elsevier
6 天前 - … Progressive disease was identified after rechemotherapy and target therapy, complete
remission can be achieved after switching to PD-1 inhibitor plus targeted therapy. These …